CLINICAL TRIALS AT
LEADING CANCER CENTERS
Leading cancer centres are where the trial frontier lives. For patients whose best option requires that frontier, knowing when to seek a referral or consultation is part of the complete treatment picture.
analyticsAt a Glance
- check_circleLeading cancer centres run more trials β and earlier phase trials β than community hospitals
- check_circleCentres like MD Anderson, Memorial Sloan Kettering, and Sun Yat-sen Cancer Center run hundreds of active trials
- check_circleInternational patients can access trials at Chinese, Indian, and other global centres
- check_circleCancerFax matches patients to specific trials based on diagnosis, mutations, and treatment history
What Distinguishes Centres With the Deepest Trial Infrastructure
NCI-Designated Cancer Centers (US)
Comprehensive Cancer Centre is the highest tier. These centres run the most trials, including early-phase and investigator-initiated programmes not available elsewhere. The ESMO-accredited equivalents serve similar roles in European settings.
Phase I Units
Early-phase trials require dedicated infrastructure for intensive monitoring and dose-escalation assessments that first-in-human studies demand. Phase I programmes are concentrated at centres with this infrastructure -- not available at most community settings.
Molecular Tumour Boards
Multidisciplinary review of complex genomic cases by oncologists, molecular pathologists, and bioinformaticians. Connect patients to trials matching unusual molecular profiles. Not available in most community settings -- and can change what options appear to be available.
COG-Member Institutions (Pediatric)
Children Oncology Group member centres have access to the full cooperative group portfolio including the newest protocols across all paediatric cancer types.
Frequently Asked Questions
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination β travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Questions About Finding the Right Centre for Clinical Trial Access?
CancerFax helps identify which centres have active trials matched to your molecular profile and facilitates consultation and referral to appropriate programmes.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.